Tag: Moderna

What You Need to Know • Moderna and Merck announced an experimental vaccine treatment shows promise in preventing melanoma recurrence. ...

What You Need to Know • The Food and Drug Administration approved Moderna's mFlusiva, the first mRNA flu vaccine in ...

The U.S. Food and Drug Administration has granted approval to Moderna's new seasonal flu vaccine, mFLUSIVA, which utilizes mRNA technology, ...

Moderna (NASDAQ: MRNA) saw its stock rise 5.5% after the FDA indicated it would accept the company's application for a ...

The pharmaceutical giant Moderna expressed optimism that its new flu shot will be available this year after the FDA accepted ...

The FDA has declined to review Moderna's flu vaccine application, citing insufficient data and questioning the product's adherence to standard ...

The FDA has rejected Moderna's application for a new flu vaccine utilizing mRNA technology, citing inadequate clinical trial comparisons. This ...

Investors initially flocked to Moderna (NASDAQ: MRNA) for its highly sought-after coronavirus vaccine, which rapidly transformed the company from a ...

Moderna (NASDAQ: MRNA) gained recognition for its role in developing a COVID-19 vaccine using innovative messenger RNA (mRNA) technology, which ...

The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, which is a lower-dose option targeting high-risk individuals aged 65 and ...